Yu Qigui, Yue Feng Yun, Gu Xiao X, Schwartz Herbert, Kovacs Colin M, Ostrowski Mario A
Clinical Sciences Division, University of Toronto, Ontario, Canada.
J Immunol. 2006 Feb 15;176(4):2486-95. doi: 10.4049/jimmunol.176.4.2486.
We have previously shown that CD4(+) T cells are required to optimally expand viral-specific memory CD8(+) CTL responses using a human dendritic cell-T cell-based coculture system. OX40 (CD134), a 50-kDa transmembrane protein of the TNFR family, is expressed primarily on activated CD4(+) T cells. In murine models, the OX40/OX40L pathway has been shown to play a critical costimulatory role in dendritic cell/T cell interactions that may be important in promoting long-lived CD4(+) T cells, which subsequently can help CD8(+) T cell responses. The current study examined whether OX40 ligation on ex vivo CD4(+) T cells can enhance their ability to "help" virus-specific CTL responses in HIV-1-infected and -uninfected individuals. OX40 ligation of CD4(+) T cells by human OX40L-IgG1 enhanced the ex vivo expansion of HIV-1-specific and EBV-specific CTL from HIV-1-infected and -uninfected individuals, respectively. The mechanism whereby OX40 ligation enhanced help of CTL was independent of the induction of cytokines such as IL-2 or any inhibitory effect on CD4(+) T regulatory cells, but was associated with a direct effect on proliferation of CD4(+) T cells. Thus, OX40 ligation on CD4(+) T cells represents a potentially novel immunotherapeutic strategy that should be investigated to treat and prevent persistent virus infections, such as HIV-1 infection.
我们之前已经表明,使用基于人树突状细胞 - T细胞的共培养系统,CD4(+) T细胞是最佳扩展病毒特异性记忆CD8(+) CTL反应所必需的。OX40(CD134)是TNFR家族的一种50 kDa跨膜蛋白,主要在活化的CD4(+) T细胞上表达。在小鼠模型中,OX40/OX40L途径已被证明在树突状细胞/T细胞相互作用中起关键的共刺激作用,这可能对促进长寿的CD4(+) T细胞很重要,随后这些细胞可以帮助CD8(+) T细胞反应。当前的研究检查了在体外CD4(+) T细胞上连接OX40是否能增强其在HIV-1感染和未感染个体中“帮助”病毒特异性CTL反应的能力。人OX40L-IgG1对CD4(+) T细胞进行OX40连接分别增强了来自HIV-1感染和未感染个体的HIV-1特异性和EBV特异性CTL的体外扩增。OX40连接增强CTL帮助作用的机制独立于细胞因子如IL-2的诱导或对CD4(+) T调节细胞的任何抑制作用,但与对CD4(+) T细胞增殖的直接影响有关。因此,在CD4(+) T细胞上连接OX40代表了一种潜在的新型免疫治疗策略,应该对其进行研究以治疗和预防持续性病毒感染,如HIV-1感染。